SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $258,000 | +59.3% | 129,827 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $162,000 | -52.6% | 129,827 | -90.0% | 0.01% | -50.0% |
Q2 2020 | $342,000 | -36.5% | 1,298,274 | 0.0% | 0.01% | -50.0% |
Q1 2020 | $539,000 | +23.1% | 1,298,274 | 0.0% | 0.03% | +33.3% |
Q4 2019 | $438,000 | -53.2% | 1,298,274 | 0.0% | 0.02% | -72.7% |
Q3 2019 | $935,000 | -0.8% | 1,298,274 | 0.0% | 0.08% | +16.7% |
Q2 2019 | $943,000 | -40.5% | 1,298,274 | 0.0% | 0.07% | -19.5% |
Q1 2019 | $1,584,000 | +193.9% | 1,298,274 | 0.0% | 0.08% | +290.5% |
Q4 2018 | $539,000 | -79.2% | 1,298,274 | 0.0% | 0.02% | -81.2% |
Q3 2018 | $2,597,000 | -5.6% | 1,298,274 | 0.0% | 0.11% | -13.2% |
Q2 2018 | $2,752,000 | -22.1% | 1,298,274 | 0.0% | 0.13% | -17.8% |
Q1 2018 | $3,531,000 | -26.3% | 1,298,274 | 0.0% | 0.16% | -20.7% |
Q4 2017 | $4,791,000 | +90.2% | 1,298,274 | 0.0% | 0.20% | +125.0% |
Q3 2017 | $2,519,000 | -28.1% | 1,298,274 | 0.0% | 0.09% | -31.2% |
Q2 2017 | $3,505,000 | -34.2% | 1,298,274 | 0.0% | 0.13% | -30.8% |
Q1 2017 | $5,323,000 | +13.3% | 1,298,274 | 0.0% | 0.18% | -1.1% |
Q4 2016 | $4,700,000 | -17.2% | 1,298,274 | 0.0% | 0.19% | -26.7% |
Q3 2016 | $5,673,000 | – | 1,298,274 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 7,600,000 | $9,234,000 | 7.03% |
Samsara BioCapital, LLC | 3,750,000 | $4,556,000 | 3.58% |
CAXTON CORP | 277,245 | $337,000 | 0.31% |
BVF INC/IL | 2,287,860 | $2,780,000 | 0.31% |
Eventide Asset Management | 5,965,455 | $7,248,000 | 0.25% |
Telemetry Investments, L.L.C. | 197,564 | $240,000 | 0.12% |
NEA Management Company, LLC | 1,298,274 | $1,584,000 | 0.08% |
RP Management, LLC | 129,517 | $158,000 | 0.08% |
Palo Alto Investors LP | 1,162,473 | $1,412,000 | 0.06% |
Fosun International Ltd | 725,000 | $863,000 | 0.06% |